Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionBalyasny Asset Management Llc
Latest Disclosed Ownership1,505 shares
Latest Disclosed Value $ 1,162,823
Balyasny Asset Management Llc ownership in REGN / Regeneron Pharmaceuticals, Inc.

On May 15, 2026 - Balyasny Asset Management Llc filed a 13F-HR form disclosing ownership of 1,505 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $1,162,823 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 68,585 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of -97.81% during the quarter.

Balyasny Asset Management Llc has a history of taking positions in derivatives of the underlying security (REGN) in the form of stock options. The firm currently holds call options representing 1,700 of underlying shares valued at $1,313,488 USD and put options representing 1,000 of underlying shares valued at $772,640 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:REGN / Regeneron Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,505 -67,080 -97.81 1,163 -97.80 0.0014
2026-02-17 2025-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 68,585 49,733 263.81 52,939 399.46 0.0672
2025-11-14 2025-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 18,852 -134,584 -87.71 10,600 -86.84 0.0134
2025-08-14 2025-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 153,436 119,909 357.65 80,554 278.84 0.1213
2025-05-15 2025-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 33,527 4,736 16.45 21,264 3.68 0.0352
2025-02-14 2024-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 28,791 20,705 256.06 20,509 141.27 0.0305
2024-11-14 2024-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 8,086 610 8.16 8,500 8.18 0.0139
2024-08-14 2024-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 7,476 -2,126 -22.14 7,858 -14.98 0.0138
2024-05-13 2024-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 9,602 -32,391 -77.13 9,242 -74.94 0.0161
2024-02-14 2023-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 41,993 40,065 2,078.06 36,882 2,225.47 0.0693
2023-11-14 2023-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,928 -665 -25.65 1,587 -14.87 0.0032
2023-08-14 2023-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 2,593 2,593 1,863 0.0041
2023-05-15 2023-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -33,457 -100.00 0 -100.00
2023-02-14 2022-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 33,457 33,457 24,139 0.0661
2022-11-15 2022-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -80,763 -100.00 0 -100.00
2022-08-15 2022-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 80,763 80,763 47,742 0.1554
2021-12-01 2021-09-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 0 -66,919 -100.00 0 -100.00
2021-11-15 2021-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -66,919 0
2021-08-16 2021-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 66,919 66,919 37,377 0.1770
2021-02-16 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -30,582 -100.00 0 -100.00
2020-11-16 2020-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 30,582 30,582 17,119 0.1255
2020-02-14 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -176,027 -100.00 0 -100.00
2019-11-14 2019-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 176,027 -83,020 -32.05 48,830 -39.78 0.3358
2019-08-14 2019-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 259,047 155,008 148.99 81,082 89.80 0.5182
2019-05-15 2019-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 104,039 57,867 125.33 42,720 147.72 0.2840
2019-02-14 2018-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 46,172 15,898 52.51 17,245 40.98 0.1243
2018-11-14 2018-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 30,274 21,238 235.04 12,232 292.43 0.0555
2018-08-14 2018-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 9,036 -165,138 -94.81 3,117 -94.80 0.0142
2018-05-15 2018-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 174,174 -30,383 -14.85 59,979 -22.01 0.2506
2018-02-14 2017-12-31 13F Regeneron Pharmaceuticals Common Stock 75886F107 204,557 204,557 17.44 76,905 28.22 0.2403
2017-11-14 2017-09-30 13F Regeneron Pharmaceuticals Common Stock 75886F107 0 -58,357 -100.00 0 -100.00
2017-08-14 2017-06-30 13F Regeneron Pharmaceuticals Common Stock 75886F107 58,357 18,857 47.74 28,661 87.24 0.1182
2017-05-15 2017-03-31 13F Regeneron Pharmaceuticals Common Stock 75886F107 39,500 39,500 -32.31 15,307 -46.59 0.0714
2013-11-14 2013-09-30 13F Regeneron Pharmaceuticals Common Stock 75886F107 0 -29,750 -100.00 0 -100.00
2013-08-14 2013-06-30 13F Regeneron Pharmaceuticals Common Stock 75886F107 29,750 29,750 6,690 0.1123
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F REGENERON PHARMACEUTICALS COM Call 1,700 -85.83 1,313 -85.82 n/a n/a n/a
2026-02-17 2025-12-31 13F REGENERON PHARMACEUTICALS COM Call 12,000 62.16 9,262 122.64 n/a n/a n/a
2025-11-14 2025-09-30 13F REGENERON PHARMACEUTICALS COM Call 7,400 -50.00 4,161 -46.46 n/a n/a n/a
2025-08-14 2025-06-30 13F REGENERON PHARMACEUTICALS COM Call 14,800 7,770 n/a n/a n/a
2025-05-15 2025-03-31 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F REGENERON PHARMACEUTICALS COM Call 1,400 -66.67 997 -77.42 n/a n/a n/a
2024-11-14 2024-09-30 13F REGENERON PHARMACEUTICALS COM Call 4,200 82.61 4,415 82.66 n/a n/a n/a
2024-08-14 2024-06-30 13F REGENERON PHARMACEUTICALS COM Call 2,300 283.33 2,417 318.89 n/a n/a n/a
2024-05-13 2024-03-31 13F REGENERON PHARMACEUTICALS COM Call 600 577 n/a n/a n/a
2024-02-14 2023-12-31 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F REGENERON PHARMACEUTICALS COM Call 5,600 0.00 4,609 14.54 n/a n/a n/a
2023-08-14 2023-06-30 13F REGENERON PHARMACEUTICALS COM Call 5,600 0.00 4,024 -12.56 n/a n/a n/a
2023-05-15 2023-03-31 13F REGENERON PHARMACEUTICALS COM Call 5,600 0.00 4,601 13.89 n/a n/a n/a
2023-02-14 2022-12-31 13F REGENERON PHARMACEUTICALS COM Call 5,600 -1.75 4,040 2.88 n/a n/a n/a
2022-11-15 2022-09-30 13F REGENERON PHARMACEUTICALS COM Call 5,700 307.14 3,927 374.28 n/a n/a n/a
2022-08-15 2022-06-30 13F REGENERON PHARMACEUTICALS COM Call 1,400 828 n/a n/a n/a
2021-12-01 2021-09-30 13F/A REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F REGENERON PHARMACEUTICALS COM Call 0 0 n/a n/a n/a
2021-08-16 2021-06-30 13F REGENERON PHARMACEUTICALS COM Call 27,400 15,304 n/a n/a n/a
2021-02-16 2020-12-31 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-16 2020-09-30 13F REGENERON PHARMACEUTICALS COM Call 100,000 55,978 n/a n/a n/a
2020-02-14 2019-12-31 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-14 2019-09-30 13F REGENERON PHARMACEUTICALS COM Call 135,000 35.00 37,449 16.93 n/a n/a n/a
2019-08-14 2019-06-30 13F REGENERON PHARMACEUTICALS COM Call 100,000 170.27 32,026 110.79 n/a n/a n/a
2019-05-15 2019-03-31 13F REGENERON PHARMACEUTICALS COM Call 37,000 -63.00 15,193 -52.56 n/a n/a n/a
2019-02-14 2018-12-31 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-14 2018-09-30 13F REGENERON PHARMACEUTICALS COM Call 105,500 58.65 40,480 76.44 n/a n/a n/a
2018-08-14 2018-06-30 13F REGENERON PHARMACEUTICALS COM Call 66,500 -38.99 22,942 -38.88 n/a n/a n/a
2018-05-15 2018-03-31 13F REGENERON PHARMACEUTICALS COM Call 109,000 -26.10 37,535 -32.31 n/a n/a n/a
2018-02-14 2017-12-31 13F Regeneron Pharmaceuticals Common Stock Call 147,500 35.32 55,454 47.74 n/a n/a n/a
2017-11-14 2017-09-30 13F Regeneron Pharmaceuticals Common Stock Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-08-14 2017-06-30 13F Regeneron Pharmaceuticals Common Stock Call 365,000 179,266 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F REGENERON PHARMACEUTICALS COM Put 1,000 -97.34 773 -97.34 n/a n/a n/a
2026-02-17 2025-12-31 13F REGENERON PHARMACEUTICALS COM Put 37,600 18.99 29,022 63.35 n/a n/a n/a
2025-11-14 2025-09-30 13F REGENERON PHARMACEUTICALS COM Put 31,600 -28.99 17,768 -23.95 n/a n/a n/a
2025-08-14 2025-06-30 13F REGENERON PHARMACEUTICALS COM Put 44,500 -19.68 23,362 -33.51 n/a n/a n/a
2025-05-15 2025-03-31 13F REGENERON PHARMACEUTICALS COM Put 55,400 -4.65 35,136 -15.10 n/a n/a n/a
2025-02-14 2024-12-31 13F REGENERON PHARMACEUTICALS COM Put 58,100 -10.06 41,386 -39.06 n/a n/a n/a
2024-11-14 2024-09-30 13F REGENERON PHARMACEUTICALS COM Put 64,600 -5.69 67,910 -5.67 n/a n/a n/a
2024-08-14 2024-06-30 13F REGENERON PHARMACEUTICALS COM Put 68,500 9.08 71,996 19.11 n/a n/a n/a
2024-05-13 2024-03-31 13F REGENERON PHARMACEUTICALS COM Put 62,800 -7.37 60,444 1.50 n/a n/a n/a
2024-02-14 2023-12-31 13F REGENERON PHARMACEUTICALS COM Put 67,800 551.92 59,548 595.82 n/a n/a n/a
2023-11-14 2023-09-30 13F REGENERON PHARMACEUTICALS COM Put 10,400 -4.59 8,559 9.27 n/a n/a n/a
2023-08-14 2023-06-30 13F REGENERON PHARMACEUTICALS COM Put 10,900 36.25 7,832 19.15 n/a n/a n/a
2023-05-15 2023-03-31 13F REGENERON PHARMACEUTICALS COM Put 8,000 0.00 6,573 13.90 n/a n/a n/a
2023-02-14 2022-12-31 13F REGENERON PHARMACEUTICALS COM Put 8,000 19.40 5,772 25.05 n/a n/a n/a
2022-11-15 2022-09-30 13F REGENERON PHARMACEUTICALS COM Put 6,700 378.57 4,615 457.37 n/a n/a n/a
2022-08-15 2022-06-30 13F REGENERON PHARMACEUTICALS COM Put 1,400 828 n/a n/a n/a
2021-12-01 2021-09-30 13F/A REGENERON PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F REGENERON PHARMACEUTICALS COM Put 0 0 n/a n/a n/a
2021-08-16 2021-06-30 13F REGENERON PHARMACEUTICALS COM Put 1,600 894 n/a n/a n/a
2017-05-15 2017-03-31 13F Regeneron Pharmaceuticals Common Stock Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-14 2016-12-31 13F Regeneron Pharmaceuticals Common Stock Put 28,800 10,572 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.